{"downloaded": true, "htmlmade": false, "full": {"id": "28078161", "source": "MED", "pmid": "28078161", "pmcid": "PMC5203900", "fullTextIdList": {"fullTextId": "PMC5203900"}, "doi": "10.1155/2016/5042604", "title": "A Case-Control Association Study of <i>RANTES (</i>-28<i>C</i>><i>G)</i> Polymorphism as a Risk Factor for Parkinson's Disease in Isparta, Turkey.", "authorString": "Sahin-Calapoglu N, Demirci S, Calapoglu M, Yasar B.", "authorList": {"author": [{"fullName": "Sahin-Calapoglu N", "firstName": "Nilufer", "lastName": "Sahin-Calapoglu", "initials": "N", "authorId": {"@type": "ORCID", "#text": "0000-0002-7376-1607"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medical Biology, Faculty of Medicine, S\u00fcleyman Demirel University, Isparta, Turkey."}}}, {"fullName": "Demirci S", "firstName": "Serpil", "lastName": "Demirci", "initials": "S", "authorId": {"@type": "ORCID", "#text": "0000-0003-1561-1296"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology, Faculty of Medicine, S\u00fcleyman Demirel University, Isparta, Turkey."}}}, {"fullName": "Calapoglu M", "firstName": "Mustafa", "lastName": "Calapoglu", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Biochemistry, Faculty of Science, S\u00fcleyman Demirel University, Isparta, Turkey."}}}, {"fullName": "Yasar B", "firstName": "Baris", "lastName": "Yasar", "initials": "B", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medical Biology, Faculty of Medicine, S\u00fcleyman Demirel University, Isparta, Turkey."}}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0002-7376-1607"}, {"@type": "ORCID", "#text": "0000-0003-1561-1296"}]}, "dataLinksTagsList": {"dataLinkstag": "altmetrics"}, "journalInfo": {"volume": "2016", "journalIssueId": "2409766", "dateOfPublication": "2016", "monthOfPublication": "0", "yearOfPublication": "2016", "printPublicationDate": "2016-01-01", "journal": {"title": "Parkinson's disease", "ISOAbbreviation": "Parkinsons Dis", "medlineAbbreviation": "Parkinsons Dis", "NLMid": "101539877", "ISSN": "2090-8083", "ESSN": "2042-0080"}}, "pubYear": "2016", "pageInfo": "5042604", "abstractText": "<i>Background</i>. Recent studies have revealed that inflammatory processes are involved in the pathogenesis of Parkinson's disease (PD). Multiple lines of evidence have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. We have examined whether genetic polymorphisms at the genes encoding chemokines <i>IL-8 (-251A>T), MCP-1 (-2518A/G)</i>, and <i>RANTES (-28C>G)</i> and chemokine receptors <i>CCR2 (V64I</i>) and <i>CCR5 (-\u039432)</i> were associated with sporadic PD risk in Isparta, Turkey. <i>Method</i>. The pilot case-control association study included 30 PD patients and 60 control subjects, who were all genotyped with PCR-RFLP for the five polymorphisms. Their genotype and haplotype frequencies were compared statistically. <i>Results</i>. One SNP <i>(-28C>G)</i> in <i>RANTES</i> revealed a significant association with PD (<i>P</i> (allele) < 0.0001, <i>p</i>-trend = 0.0007). The risk allele <i>(G)</i> in the homozygous and dominant models (OR = 17.29 and 32.10, 95% CI = 0.86-347.24 and 1.74-591.937, resp.) suggests additional PD risk. The haplotype <i>TGCAN</i> from the <i>IL-8 (-251A>T), MCP-1 (-2518A>G), RANTES (-28C>G), CCR-2 (V64I)</i>, and <i>CCR-5 (-\u039432)</i> has protective effect (OR = 0.08 [CI = 0.01-0.63], <i>p</i> = 0.019). <i>Conclusions</i>. Our data are the first indication of the role of <i>RANTES (-28C>G)</i> in PD risk.", "affiliation": "Department of Medical Biology, Faculty of Medicine, S\u00fcleyman Demirel University, Isparta, Turkey.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["research-article", "Journal Article"]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1155/2016/5042604"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC5203900"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC5203900?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "5", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCreation": "2017-01-13", "firstIndexDate": "2017-01-14", "fullTextReceivedDate": "2020-07-12", "dateOfRevision": "2020-09-28", "electronicPublicationDate": "2016-12-18", "firstPublicationDate": "2016-12-18"}, "htmllinks": "https://europepmc.org/articles/PMC5203900", "abstract": "<i>Background</i>. Recent studies have revealed that inflammatory processes are involved in the pathogenesis of Parkinson's disease (PD). Multiple lines of evidence have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. We have examined whether genetic polymorphisms at the genes encoding chemokines <i>IL-8 (-251A>T), MCP-1 (-2518A/G)</i>, and <i>RANTES (-28C>G)</i> and chemokine receptors <i>CCR2 (V64I</i>) and <i>CCR5 (-\u039432)</i> were associated with sporadic PD risk in Isparta, Turkey. <i>Method</i>. The pilot case-control association study included 30 PD patients and 60 control subjects, who were all genotyped with PCR-RFLP for the five polymorphisms. Their genotype and haplotype frequencies were compared statistically. <i>Results</i>. One SNP <i>(-28C>G)</i> in <i>RANTES</i> revealed a significant association with PD (<i>P</i> (allele) < 0.0001, <i>p</i>-trend = 0.0007). The risk allele <i>(G)</i> in the homozygous and dominant models (OR = 17.29 and 32.10, 95% CI = 0.86-347.24 and 1.74-591.937, resp.) suggests additional PD risk. The haplotype <i>TGCAN</i> from the <i>IL-8 (-251A>T), MCP-1 (-2518A>G), RANTES (-28C>G), CCR-2 (V64I)</i>, and <i>CCR-5 (-\u039432)</i> has protective effect (OR = 0.08 [CI = 0.01-0.63], <i>p</i> = 0.019). <i>Conclusions</i>. Our data are the first indication of the role of <i>RANTES (-28C>G)</i> in PD risk.", "pdflinks": "https://europepmc.org/articles/PMC5203900?pdf=render", "journaltitle": "Parkinson's disease", "authorinfo": ["Sahin-Calapoglu N", "Demirci S", "Calapoglu M", "Yasar B"], "title": "A Case-Control Association Study of <i>RANTES (</i>-28<i>C</i>><i>G)</i> Polymorphism as a Risk Factor for Parkinson's Disease in Isparta, Turkey."}